|1.||Ereqat, Suheir: 1 article (12/2010)|
|2.||Berlin, Dalia: 1 article (12/2010)|
|3.||Abdeen, Ziad: 1 article (12/2010)|
|4.||Nasereddin, Abedelmajeed: 1 article (12/2010)|
|5.||Baneth, Gad: 1 article (12/2010)|
|6.||Azmi, Kifaya: 1 article (12/2010)|
|7.||Renggli, Christina Kunz: 1 article (03/2006)|
|8.||Voncken, Frank: 1 article (03/2006)|
|9.||Seebeck, Thomas: 1 article (03/2006)|
|10.||Richter, Christina: 1 article (03/2006)|
12/01/1958 - "rhodesiense infections in mice were compared: the CD50 for compound 12,065 was 6.5 mg./kg. and for melarsen oxide/BAL was 3.7 mg./kg. The ratios LD50/CD50 for the drugs were about 4 and 6 respectively."
03/01/1994 - "An infection with a melarsen oxide-refractory isolate was cured by a combination of low-dose DFMO (0.5% in the drinking water) plus low-dose suramin (1 mg/kg of body weight given intraperitoneally). "
03/01/1994 - "Combinations of DL-alpha-difluoromethylornithine (DFMO; eflornithine; Ornidyl) with either suramin or melarsen oxide were found to be effective against acute laboratory model infections with Trypanosoma brucei rhodesiense. "
09/01/1993 - "evansi infections by the introduction of a new arsenic compound, melarsenoxide cysteamine, chemotherapy of T. "
12/01/1948 - "Melarsen oxide in the treatment of human trypanosomiasis."
05/01/1992 - "A comparison was made between the efficacy of mel Cy (Cymelarsan) and melarsen oxide to cure central nervous system trypanosomiasis in a chronic Trypanosoma brucei mouse model. "
05/01/1992 - "Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system."
|3.||Body Weight (Weight, Body)
|5.||African Trypanosomiasis (Nagana)
|2.||Suramin (Suramin Sodium)
|5.||Melarsoprol (Mel B)
|1.||Drug Therapy (Chemotherapy)